ZTTK syndrome is an ultrarare neurodevelopmental disorder, that was only discovered in 2016. There are only 50+ patients identified in the scientific literature today and no known treatments/cures
All documented cases of ZTTK syndrome are de novo mutation resulting in haploinsufficiency, with a complex and highly varied multi-system phenotype. The most prevalent symptoms include global developmental delay (gross motor, feeding, and speech delays), intellectual disability, and seizures (~50% of the known population)
Company Details
- Employees
- 5
- Founded
- -
- Industry
- Non-Profit Organizations
- Website
- http://www.zttk.org
- Keywords
- San Diego.
Zttk Son-Shine Foundation Questions
Zttk Son-Shine Foundation's website is http://www.zttk.org
Zttk Son-Shine Foundation's LinkedIn profile is https://www.linkedin.com/company/zttk
Zttk Son-Shine Foundation has
5 employees.
View email and phone details for 5
employees at Zttk Son-Shine Foundation.
Zttk Son-Shine Foundation's industry is
Non-profit Organizations
Zttk Son-Shine Foundation's top competitors are
Nyse,
Citizen Health,
Thermo Fisher Scientific,
Pathtraker,
Andrea Machado Arquitectura,
Rady Children's Institute For Genomic Medicine,
Alexion Pharmaceuticals, Inc.,
Chan Zuckerberg Initiative,
Everylife Foundation For Rare Diseases,
Genentech.
Zttk Son-Shine Foundation's categories are Non-profit Organizations
Zttk Son-Shine Foundation's founding year is 2021
